Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy?

  1. Ann G. Zauber, PhD;
  2. Marjolein van Ballegooijen, MD, PhD; and
  3. Karen M. Kuntz, ScD
  1. From Memorial Sloan-Kettering Cancer Center, New York, NY 10065; Erasmus Medical Center, 3000CA Rotterdam, the Netherlands; and University of Minnesota, Minneapolis, MN 55455.

    IN RESPONSE:

    We agree that an interesting finding from our analysis (1) for the USPSTF is that all the screening strategies now recommended by the USPSTF are nearly equivalent for life-years gained with screening when all have equivalent 100% adherence. We note that the USPSTF recommendation for the strategies of a highly sensitive guaiac or immunochemical fecal occult blood test (FOBT) annually, flexible sigmoidoscopy every 5 years with a sensitive …

    « Previous | Next Article »Table of Contents